Literature DB >> 18346164

Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults.

C-H Kim1, J-Y Park, K-U Lee, J-H Kim, H-K Kim.   

Abstract

AIMS: To investigate whether fatty liver per se is an independent risk factor of incident type 2 diabetes mellitus (T2DM) in Koreans.
METHODS: We examined the clinical and laboratory data of 5372 non-diabetic participants (3670 men and 1702 women; age 46.8 +/- 8.4 years, range 20-79 years) who underwent voluntary medical check-ups in 2000 and follow-up examinations in 2005.
RESULTS: Two hundred and thirty-three participants (4.3%) developed T2DM after 5 years. Univariate analysis showed that the development of diabetes was associated with: male sex; family history of diabetes; smoking; older age; higher body mass index (BMI), systolic and diastolic blood pressure, fasting plasma glucose (FPG), hepatic enzymes, total cholesterol and triglycerides; lower HDL cholesterol; and the presence of fatty liver on ultrasonography at baseline. In multiple logistic regression models, after adjusting for age, sex and alcohol consumption, patients with fatty liver were at significantly higher risk of developing T2DM compared to those without fatty liver [relative risk (RR) 3.92, 95% confidence interval (CI) 2.89-5.31]. After further adjustment for smoking, BMI, triglycerides, HDL cholesterol, FPG, alanine aminotransferase and ultrasonographer, fatty liver remained significantly associated with the development of T2DM (RR 1.51, 95% CI 1.04-2.20). Patients with moderate to severe fatty liver had higher risk ratios than patients with mild fatty liver. Exclusion of frequent drinkers did not attenuate the association.
CONCLUSIONS: Fatty liver on ultrasonography is associated with the development of T2DM, independently of classical risk factors, in Korean adults.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18346164     DOI: 10.1111/j.1464-5491.2008.02410.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  42 in total

Review 1.  NAFLD/NASH in patients with type 2 diabetes and related treatment options.

Authors:  M G Radaelli; F Martucci; S Perra; S Accornero; G Castoldi; G Lattuada; G Manzoni; G Perseghin
Journal:  J Endocrinol Invest       Date:  2017-11-30       Impact factor: 4.256

2.  Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease.

Authors:  Alita Mishra; Zobair M Younossi
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

Review 3.  The Role of Non-alcoholic Fatty Liver Disease in Cardiovascular Disease.

Authors:  Sven M Francque
Journal:  Eur Cardiol       Date:  2014-07

Review 4.  Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?

Authors:  Henry Völzke
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

Review 5.  Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease.

Authors:  Sara Heebøll; Karen Louise Thomsen; Steen B Pedersen; Hendrik Vilstrup; Jacob George; Henning Grønbæk
Journal:  World J Hepatol       Date:  2014-04-27

6.  Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.

Authors:  Shira Zelber-Sagi; Muriel Webb; Nimer Assy; Laurie Blendis; Hanny Yeshua; Moshe Leshno; Vlad Ratziu; Zamir Halpern; Ran Oren; Erwin Santo
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

7.  Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study.

Authors:  Beverley Balkau; Celine Lange; Sylviane Vol; Frederic Fumeron; Fabrice Bonnet
Journal:  BMC Gastroenterol       Date:  2010-06-07       Impact factor: 3.067

8.  C-reactive protein and gamma-glutamyltransferase concentrations in relation to the prevalence of type 2 diabetes diagnosed by glucose or HbA1c criteria in Chinese adults in Qingdao, China.

Authors:  J Ren; Z C Pang; W G Gao; H R Nan; S J Wang; L Zhang; Q Qiao
Journal:  Exp Diabetes Res       Date:  2010-11-07

9.  Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease.

Authors:  Teruki Miyake; Teru Kumagi; Masashi Hirooka; Shinya Furukawa; Osamu Yoshida; Mitsuhito Koizumi; Shin Yamamoto; Takao Watanabe; Yasunori Yamamoto; Yoshio Tokumoto; Eiji Takeshita; Masanori Abe; Kohichiro Kitai; Bunzo Matsuura; Yoichi Hiasa
Journal:  J Gastroenterol       Date:  2016-03-12       Impact factor: 7.527

10.  Differences in the risk of fatty liver for onset of impaired fasting glucose according to baseline plasma glucose levels.

Authors:  Teruki Miyake; Masashi Hirooka; Osamu Yoshida; Shinya Furukawa; Teru Kumagi; Mitsuhito Koizumi; Shin Yamamoto; Taira Kuroda; Eiji Arimitsu; Eiji Takeshita; Masanori Abe; Kohichiro Kitai; Bunzo Matsuura; Yoichi Hiasa
Journal:  J Gastroenterol       Date:  2016-06-24       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.